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INTRODUCTION
Aldehyde oxidases (AOX; EC 1.2.3.1) are molybdo-flavoenzymes present in the cytosol of various tissues and animal species (Garattini et al., 2008) . The number of active AOX genes varies according to the animal species considered. While a single AOX protein is known in humans, at least four AOX enzymes (AOX1, AOX3, AOX4 and AOX2, Figure 1) encoded by distinct genes have been described for the mouse and other rodents including rats (Garattini et al., 2009 ). The four mouse Aox genes cluster on chromosome 1 at a short distance from one another (Figure 1 ). The human genome is characterized by an active gene homologous to mouse Aox1 and two inactive pseudogenes (Garattini et al., 2008) .
The biochemical and physiological functions of mammalian AOXs are still unclear (Garattini et al., 2008) . Nevertheless, human AOX1 is an enzyme of emerging relevance for phase I drug metabolism (Garattini and Terao, 2012; Kitamura and Sugihara, 2014) . Indeed, the number of xenobiotics acting as human AOX1 substrates is increasing. In particular, the current trend in drug development, focusing on the design and synthesis of molecules that are not recognized and inactivated by cytochrome P-450 dependent monoxygenases, has resulted in an enrichment of molecules which can be oxidized by AOXs (Pryde et al., 2010; Garattini and Terao, 2012) . Very little is known about the physiological substrates of human AOX1 and other mammalian AOXs. AOXs are deemed to be involved in the oxidation of all-trans the two proteins are observed in liver, lung, and testis (Vila et al., 2004) . Significant amounts of mAOX4 are detectable in the skin, the epithelium lining the oral cavity, the esophagus and the Harderian gland, the major exocrine gland of the orbital cavity in many vertebrates.
Knock-out of the gene coding for mAOX4 causes perturbations in the circadian rhythm and resistance to diet-induced obesity (Terao et al., 2016) . The expression of mAOX2 is restricted to the nasal cavity. High levels of the corresponding transcript and protein are detectable especially in Bowman's gland and olfactory mucosa (Terao et al., 2000) . It has been suggested that the different mouse aldehyde oxidase enzymes have different substrate specificities. So far, mAOX3 is the only mouse AOX for which a crystal structure is available (PDB ID: 3ZYV) (Coelho et al., 2012) , while the crystal structure of human AOX1 has recently been solved . The structures were very similar in respect to their active sites, which suggested an overlapping spectrum of substrates. Comparisons between the crystal structures of hAOX1 and mAOX3 demonstrated differences between the two enzymes in the position of one loop at the FAD site, the site of oxygen reduction. The loop close to the FAD pocket (T 1230 RGPDQ 1235 ) of hAOX1 is flipped by almost 180° relative to the mAOX3 counterpart.
AOXs are cytosolic proteins and use molecular oxygen as the sole electron acceptor.
During substrate oxidation and molecular oxygen reduction, AOXs generate significant amounts of H 2 O 2 in addition to toxic O 2 .-radicals. This specific aspect of AOXs activity has been largely overlooked and may be of patho-physiological interest. In fact, significant levels of AOX activity are present in different tissues and AOX-dependent O 2 .-production may contribute to damage by reactive oxygen species in vivo. Given these reasons and their potential relevance for the human enzyme, it is interesting to evaluate whether there are differences in the generation of O 2 .-among the four mouse AOX enzymes.
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In this study, we set up and optimized an efficient system for the heterologous expression of the four mouse AOX enzymes in Escherichia coli. We used this system to purify significant amounts of highly purified and active mAOX1, mAOX3, mAOX4 and mAOX2. We compared the kinetic and spectroscopic properties of the four enzymes using a selected number of potential substrates. In addition, we determined the levels of superoxide anions generated by each enzyme. Our data reveal significant differences in the enzymatic characteristics and substrate specificities of the mouse AOX enzymes. This is of relevance for the use of mouse as an animal model in the context of drug discovery programs. The results presented support the idea that mice and other rodents are unlikely to represent suitable models for drug metabolism predictions in humans.
8 centrifugation at 18000 g for 1 h at 4°C. The supernatants were loaded onto Ni-NTA (QIAGEN, Valencia, CA) columns using 0.3 ml of resin per liter of culture. The matrix was washed with 20 column volumes of the following two buffers consecutively: 1) 50 mM sodium phosphate pH.8.0, 300 mM NaCl and 10 mM imidazole; 2) 50 mM sodium phosphate pH.8.0, 300 mM NaCl and 20 mM imidazole. Proteins were eluted with 50 mM sodium phosphate pH.8.0, 300 mM NaCl and 250 mM imidazole. For the further purification steps, the elution buffer was exchanged to 50 mM Tris-HCl, 200 mM NaCl and 1 mM EDTA (pH 8.0) with the use of PD-10 columns (GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK). The purified enzymes were concentrated by ultrafiltration (Amicon 50-kDa MW cutoff; Milipore Corporation, Billerica, MA). This was followed by size exclusion chromatography on Superdex 200 columns (GE Healthcare) equilibrated in 50 mM Tris-HCl, 200 mM NaCl and 1 mM EDTA (pH 8.0). Each fraction was analyzed by SDSpolyacrylamide gel electrophoresis (PAGE) and only the fractions containing dimeric AOX proteins were combined. Purified proteins were stored at -80 °C until further use.
Chemical in vitro sulfuration
Purified enzymes were subjected to an in vitro chemical sulfuration step using a slight modification of a previously described protocol (Wahl and Rajagopalan, 1982) . Proteins dissolved in buffer (50 mM Tris-HCl, pH 8.0, containing 200 mM NaCl and 1 mM EDTA)
were incubated in an anaerobic chamber (Coy Laboratory Products, Grass Lake, MI) with sodium sulfide (2 mM) as the sulfur source and sodium dithionite (1 mM) to facilitate reduction. Methyl viologen (25 µM) was used as an anaerobic indicator of the reaction. After 1.5 h incubation at 4°C, reactions were stopped and the enzyme was equilibrated in 50 mM
Tris-HCl, 200 mM NaCl and 1 mM EDTA (pH 8.0) using a PD-10 column.
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Polyacrylamide Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis (PAGE) was performed with 10% gels under reducing conditions (β-mercaptoethanol) using a standard protocol (Laemmli, 1970) . Gels were stained with Coomassie Brilliant Blue R (Sigma, Munich, Germany). The molecular weight of the separated proteins was determined by comparison with a protein standard (molecular weight marker, MWM; Fermentas/Thermo Fisher Scientific).
Native-PAGE was performed with 7% gels under non-reducing and non-denaturing conditions. Samples were separated at a constant voltage of 40 V. Gels were stained with
Coomassie Brilliant Blue R. The in-gel enzymatic activity was visualized by staining with 500 µM substrate (phthalazine or pyridoxal-5-monophosphate) and 1 mM Nitro blue tetrazolium chloride (NBT) in 50 mM Tris buffer.
Ultraviolet-Visible Spectroscopy Absorption Spectroscopy
UV-visible absorption spectra of enzymes were recorded in 500 µl quartz cuvettes using a Shimadzu UV-2600 spectrophotometer (Somerset, NJ). The specific molar extinction coefficient of 21000 M -1 cm -1 at 450 nm was used to determine the concentration of proteins.
NADH reduction was achieved by the addition of 1 mM NADH. Spectra were recorded under anaerobic conditions to avoid the re-oxidation of enzymes by oxygen.
Steady-state Kinetics
This article has not been copyedited and formatted. The final version may differ from this version. Figure S1 ). 2,6 dichlorophenolindophenol (DCPIP) at a concentration of 100 µM was used as the electron acceptor, which is converted to the colorless DCPIPH 2 leuco-form in a two-electron reduction step. The total enzyme concentration varied between 0.05 and 0.2 µM, depending on the AOX enzyme used.
Enzyme activity was monitored at 600 nm with a computer-assisted spectrophotometer (Shimadzu UV-2600) coupled to a temperature controlled cell holder (Shimadzu TCC-240A).
Enzymatic activities were converted to turnover number (k cat ) using the molar extinction 
Superoxide Production
The amount of superoxide produced during the enzymatic reactions was measured by 
Quantification of molybdenum and iron
The molybdenum and iron contents of the purified AOX enzymes were determined by inductively coupled plasma optical emission spectrometry (ICP-OES) with an Optima 2100 
RESULTS

Purification of the mAOX enzymes from E. coli.
To compare the spectroscopic and kinetic properties of mAOX1, mAOX3, mAOX4
and mAOX2, we expressed the four mouse enzymes in a heterologous expression system in E. coli. Efficient expression of the recombinant mAOX3 protein in E. coli cells has been described previously (Schumann et al., 2009; Mahro et al., 2011) and has resulted in a calculated yield of 0.8 mg/Liter (Table 1) . Under the same expression conditions, the yield of the mAOX1 protein from the corresponding native cDNA was relatively poor (Schumann et al., 2009 ). To overcome this problem, we generated an expression construct based on an E.
coli codon-optimized mAox1 gene that resulted in a 150-fold increased average yield of mAOX1 (Table 1) . In contrast to the previously described purification protocols, both mAOX1 and mAOX3 were purified by a simplified two-step purification method using Ni-NTA and size exclusion chromatography. This resulted in increased yields of proteins characterized by an equal level of purity.
In contrast, the expression systems for mAOX2 and mAOX4 were not established before. The construct used for the expression of mAOX4 in E. coli TP1000 contained the original cDNA amplified from the Harderian gland of C57BL/6N mice. For the expression of mAOX2, we generated an E. coli codon optimized construct in analogy to the one described for mAOX1. As detailed in the case of mAOX1 and mAOX3, the mAOX2 and mAOX4
proteins were purified from 12 liters of E. coli TP1000 cells. Similar to mAOX1 and mAOX3, the mAOX4 and mAOX2 enzymes were purified by the 2-step purification procedure involving Ni-NTA and size-exclusion chromatography. Upon size-exclusion chromatography, mAOX1, mAOX2 mAOX3 and mAOX4 eluted as a single major peak, which corresponded to the catalytically active dimeric forms of each enzyme with a molecular mass of 300 kDa ( Figure 2 ). Monomers were also detectable for all AOX enzymes
This article has not been copyedited and formatted. The final version may differ from this version. as minor peaks with an elution volume around 12.5 ml. In the case of AOX4, a substantial amount of protein showed the tendency to aggregate, however, the aggregates were well separated from the main dimeric peak upon size exclusion chromatography ( Figure 2 ). The total yield of mAOX4 with an average of 1.1 ± 0.4 mg protein per liter of E. coli culture was slightly higher than that of mAOX2, resulting in 0.8 ± 0.2 mg protein per liter of E. coli culture (Table 1 ).
Relative to other molybdoenzymes, AOXs are characterized by the presence of a terminal sulfido ligand in the equatorial position of Moco. This sulfido ligand is essential for the catalytic activity of both types of enzymes and it is inserted by a specific Moco sulfurase (Anantharaman and Aravind, 2002; Mendel and Leimkuhler, 2015; Terao et al., 2016) . As the E. coli and eukaryotic Moco sulfurases are substantially distinct from each other, expression of mammalian AOXs in E. coli generally results in a low saturation level of the terminal Mo=S group (Mahro et al., 2011; Foti et al., 2016) . However, after purification, the sulfido ligand can be ligated to the Moco of these enzymes by using a chemical sulfuration procedure (Wahl and Rajagopalan, 1982) . Consistent with the above considerations, expression of the mAOX3 and mAOX4 in E. coli resulted in the isolation of two proteins with a low catalytic activity, which could be increased more than 10-fold following the chemical sulfuration step (Table 1 ). In the case of the two codon-optimized constructs used for mAOX1 and mAOX2
expression in E. coli, they resulted in the production of two catalytically inactive proteins (Table 1) . However, mAOX1 and mAOX2 regained significant activity upon chemical sulfuration.
The UV-Vis spectra of mAOX1, mAOX3, mAOX4 and mAOX2 displayed the (XO) and AOX. A ration of A465/A550 of 3.0 corresponds to a FAD to iron ratio of 1:4, while the ratio of A280/A465 of 5.0 is indicative for a high purity of the enzyme. Generally, the 280/450 nm absorption ratios of mAOX1, mAOX4, and mAOX2 were 5.7, 5.4, and 5.0, respectively (Table 1) , which is consistent with a high level of enzyme purity. The similar 450/550 ratios determined for the enzymes are in line with the FAD and [2Fe2S] saturation levels ( Table 1) .
SDS-polyacrylamide gels performed with the purified enzymes under reducing conditions with β-mercaptoethanol and showed the presence of one major 150 kDa band in the case of mAOX1 and mAOX3. Under the same conditions, mAOX4 and mAOX2 were not fully reduced, as slower migrating bands, representing the corresponding multimeric forms, were readily detectable (Figure 2A-D) . The bands around 130 kDa, 80 kDa, and 50 kDa identified for all enzymes (Kundu et al., 2007; Mahro et al., 2011) , corresponded to degradation products, as confirmed by electrospray mass spectroscopy analysis (data not shown).
The levels of molybdenum and iron saturation for purified AOX1, AOX3, AOX4 and AOX2 were determined by inductively coupled plasma optical emission spectroscopy ( Figure   3 ). In the case of mAOX1, molybdenum saturation levels around 40% were calculated, while approximately 50% values were detected for mAOX3, mAOX4 and mAOX2. The iron saturation levels were around 60% for all the enzymes and reflected the saturation with 2x[2Fe2S] clusters. In conclusion, heterologous expression of the four mAOX enzymes in E.
coli resulted in incomplete but comparable overall metal and cofactor saturation. The incomplete saturation with Moco and [2Fe2S] clusters has been reported before for other molybdoflavoenzymes expressed in E. coli (Mahro et al., 2011; Hartmann et al., 2012; Foti et al., 2016) . For the purification of AOX enzymes from native sources like mouse livers, however, cofactor saturation levels were generally not reported for comparison (Terao et al., 2001 ).
Direct comparison of the activities of the mAOX enzymes with selected substrates.
To compare the kinetic parameters of mAOX1, mAOX3, mAOX4 and mAOX2, the steady-state kinetics of the four enzymes were determined with pyridoxal, vanillin, 4-(dimethylamino)cinnamaldehyde (p-DMAC), N 1 -methylnicotinamide, salicylaldehyde, and retinaldehyde as substrates. These substrates were selected, since they are of physiological and toxicological interest and were reported before to be used as substrates for rat, human, rabbit or mouse AOX enzymes isolated from liver extracts (Stanulović and Chaykin, 1971; Stell et al., 1989; Obach, 2004; Kitamura et al., 2008; Terao et al., 2009 ) The kinetic parameters were determined by a spectrophotometric assay based on the 2-electron reduction of the electron acceptor DCPIP to DCPIPH 2 . The K M and k cat values calculated for each AOX enzyme and substrate are shown in Table 2 . To obtain better comparability of the data across the four AOXs, the kinetic constants were corrected and normalized for a 100% molybdenum saturation level of the purified enzymes.
As for mAOX1, the most efficient substrate is p-DMAC with a catalytic efficiency of 34.1 min -1 µM ( observation, we further evaluated the ability of mAOX1, mAOX3, mAOX4 and mAOX2 to oxidize pyridoxal, using an active enzyme staining assay based on native polyacrylamide gel electrophoresis under non-reducing conditions (Marelja et al., 2014) . In fact, this assay allows long incubation times with the selected AOX substrate and it is characterized by an unmatched level of sensitivity under these experimental conditions. After separation, the four mAOXs migrated as single bands confirming the purity of our preparations (Figure 4 ). More importantly, no signal was observed in correspondence to the mAOX1, mAOX3, mAOX4
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In contrast, easily detectable bands were observed when the gels are challenged with phthalazine as a substrate even after a much shorter incubation time (Figure 4 ). Taken together, these results fully confirm the observation that pyridoxal is not a substrate of any of the mAOX enzymes and reveal that the enzymes unlikely play a significant role in the catabolism of vitamin B6 (Stanulović and Chaykin, 1971; Garattini et al., 2008) .
mAOX3 is the sole enzyme with NADH oxidase activity.
We investigated differences at the flavin site of the mAOX enzymes. AOX enzymes are characterized by the exclusive use of molecular oxygen as electron acceptor. In contrast, the other molybdo-flavoenzyme, xanthine dehydrogenase (XDH), uses NAD + as the electron acceptor in its dehydrogenase form, while it solely transfers the reducing equivalents to molecular oxygen upon conversion into its oxidase form (XO) (Okamoto et al., 2013) .
Despite the inability to react with NAD + , XO can be reduced by NADH (Olson et al., 1974) .
The ability of XO to interact with NADH, but not with NAD + , is a consequence of the different redox potentials of the FAD cofactor in the XDH and XO forms. For these reasons, we determined the relative ability of the four mAOX enzymes to oxidize NADH in the absence of oxygen ( Figure 5 ). Approximately 10 µM of each enzyme was incubated with 500
µM NADH under anaerobic conditions and the corresponding absorption spectra were recorded after 1 and 20 minutes of incubation. NADH was able to reduce only mAOX3 and complete reduction was observed after 20 min of incubation. The result supports the data from the crystal structure showing that the environment around FAD is different in mAOX3
relative to mAOX1, mAOX4 or mAOX2 (Coelho et al., 2012) .
This article has not been copyedited and formatted. The final version may differ from this version. -production, the reduction of cytochrome c (U/µmol enzyme) was related to the overall rate of substrate consumption (U/µmol enzyme) (Table 3) determined by the product formation using vanillin and p-DMAC as substrates. The results in Table 3 show that mAOX2 is characterized by the highest rate of superoxide production per substrate turnover. Indeed, the enzyme produces approximately 40% of O 2 .-during turnover with vanillin and p-DMAC. In terms of O 2 .-production, mAOX2 is followed by mAOX1 with a superoxide production rate of around 30% per mol of substrate converted. The lowest percentage of these radical species is observed with mAOX3 and mAOX4 which produce around 20% of superoxide radicals during substrate turnover. Since the same ratios of O 2 .-/substrate converted were obtained with different substrates used in the assay, the ratio seems to be independent of the substrate used.
This article has not been copyedited and formatted. The final version may differ from this version. is 85% identical to mouse AOX1, while the other enzymes differ by 61-65% among each other (Garattini and Terao, 2011). Combinations of homology modeling and molecular dynamics simulations demonstrated major differences among mAOX1, mAOX3, mAOX4, and mAOX2 at the protein surface and in the substrate-binding region (Cerqueira et al., 2015) . In particular, specific amino acids characteristic for each enzyme in the substratebinding site were predicted to be responsible for differences in the catalytic activity, substrate and inhibitor specificities (Vila et al., 2004 ).
Here we report on the purification of the four mouse AOX enzymes in the heterologous expression system represented by the E. coli TP1000 strain to directly investigate differences among the different enzymes. The major aim of the study was to compare the catalytic activities of mAOX1, mAOX3, mAOX4 and mAOX2 directly and without cross-contaminations of the other enzymes, as it might have been the case with the native enzymes purified from mouse tissues. A study directly comparing the purified enzymes has not been reported before and is helpful to explain differences in previous studies Kundu et al., 2012) . We optimized and applied the same method for the purification of the four mouse AOXs. The established method is based on a two-step purification protocol involving Ni-NTA and size exclusion chromatography. The procedure resulted in pure enzymes and an increased yield as compared to the previous purification procedures described for recombinant mAOX1 and mAOX3 (Schumann et al., 2009; Mahro et al., 2011) . The high yields of mAOX1 and mAOX2 are a consequence not only due to the changes in the purification method, but also to the use of a codon-optimized expression vector and a chemical sulfuration step. The combination of these two factors gave rise to a 150-fold increase in the yield of mAOX1.
We profiled the four mouse AOX enzymes with three potential substrates of So far, one or more unspecified mouse AOX enzymes have been deemed to be involved in nicotinamide metabolism thanks to their ability to generate pyridones (Stanulović and Chaykin, 1971) . Interestingly, our data indicate that mAOX1 and mAOX4 do not recognize Nin this tissue (Stanulović and Chaykin, 1971; Kitamura et al., 2008) . The metabolism of N 1 -methylnicotinamide by human AOX1 has not been investigated with the purified enzyme before. Studies on humanized mice extracts showed some discrepancies in respect to product formation in comparison to the products in mice, thus, we only can speculate here whether N 1 -methylnicotinamide is indeed a substrate of hAOX1 (Kitamura et al, 2008) . A recent computational study predicted structural differences in the substrate binding funnel of the four mouse AOXs (Cerqueira et al., 2015) . In particular, mAOX1 has been proposed to be endowed with the widest substrate binding region, while mAOX4 has been predicted to contain the narrowest one. The experimental results obtained with N 1 -methylnicotinamide are not entirely consistent with the predictions. In fact, neither mAOX1 nor mAOX4 utilize this substrate, while N 1 -methylnicotinamide is a good mAOX2 and mAOX3 substrate (Mahro et al., 2013) .
Pyridoxal is one of the forms of vitamin B6 and a potential physiological substrate of human AOX1 (KEGG pathways). Previous data indicated that the native form of mAOX3, purified from liver, was capable of oxidizing pyridoxal into pyridoxic acid, while the native form of mAOX4, purified from the Harderian gland, was unable to oxidize this aldehyde into the corresponding carboxylic acid (Terao et al., 2009) . The results of the current study demonstrate, however, the inability of the four recombinant mAOX enzymes to recognize pyridoxal as a substrate. At present, we do not have any explanation for the discrepancy observed between the results obtained with native and recombinant mAOX3. However, from the results on the mouse enzymes it only can be predicted that pyridoxal is also not a substrate of the human enzyme. This needs to be further investigated in future studies.
We used our purified mAOX enzymes to test the reactivity of the above substrates at the FAD site. In particular, we determined NADH oxidase activity and the amount of O 2 .-radical production from molecular oxygen. NADH is found in all living cells and it is the This article has not been copyedited and formatted. The final version may differ from this version. (Kundu et al., 2007; Maia et al., 2007; Choughule et al., 2015) . However, most of these studies were based on the use of hepatic cytosolic extracts obtained from rats or rabbits containing mixtures of AOX1 and AOX3. Even a study by Maia et al. 2015 , which investigated nitrate reductase activity using rat liver and human liver extracts, investigated the NADH oxidase activity only with the rat liver extracts and not with the human source (Maia et al., 2015) . Our results indicate that mAOX3 is the only enzyme which can be reduced by NADH. mAOX3 is the major AOX enzyme expressed in mouse liver, hence, it is possible that the associated NADH oxidase is capable of producing significant amounts of O 2 .-in this tissue. As mAOX1 is the human AOX1 orthologue, it is likely that hAOX1 is also incapable of reacting with NADH. The different reactivity with NADH of AOX1 and AOX3
can be explained by the crystal structure of the enzymes, where a different loop at the FAD site of hAOX1 and mAOX3 became visible. The crystal structure of hAOX1 revealed that a loop close to the FAD pocket (T 1230 RGPDQ 1235 ) is flipped by almost 180° relative to mouse AOX3. Thus, the NADH binding site might be blocked by this loop in AOX1 enzymes and likely also in the AOX4 and AOX2 enzymes, for which no structural data are available so far.
However, studies on the reducibility of hAOX1 by NADH are missing in the literature so far.
All studies available were investigating rat liver or rabbit liver extracts, thus, from our data it can be concluded that the NADH oxidase activity reported in these studies is mainly based on the activity of AOX3.
So far mainly xanthine oxidase (XO) has been implicated to generate significant amounts of O 2 .-during the course of their catalytic activity against recognized substrates (Kundu et al., 2007) . However, taking into account the relative levels of enzymatic activity of XO and AOX in human liver (Krenitsky et al., 1972) , AOX1 has been calculated to generate 24-fold larger amounts of superoxide than XO. Thus, human AOX1 has been suggested to represent a significant source of ROS in the cytosol and therefore might play a critical role in in ROS-mediated tissue injury under specific conditions (Kundu et al., 2012) . Given this background, we compared the production of O 2 .-by purified mAOX1, mAOX3, mAOX4 and mAOX2. Our results indicate a different rate of O 2 .-production by each mouse AOX enzyme in relation to the amount of substrate converted (in mol O 2 .-produced per mol of substrate converted). This ratio seems to be independent of the substrate used, since the same ratios of O 2 .-/substrate converted were obtained with different substrates used in the assay. In particular, mAOX2 is the most efficient producer of superoxide anions with a rate of 40%. As the enzyme is located in the nasal mucosa, which is one of the main site of entrance for infective agents, it is possible to speculate that mAOX2 produces reactive ROS to protect mice from viral and bacterial infections. A similar role may be played by mAOX1 and/or mAOX3 in the liver. Also mAOX1 was shown to produce a ratio of 30% superoxide radicals, which is higher than the reported value of 15-20% for XO (Hunt and Massey, 1992) . Thus, also hAOX1 might be a major source of superoxide radical production in the human liver. In contrast, mAOX3 and mAOX4 produce a rate of 20% O 2 .-radicals per mole of substrate converted, a ratio which is significantly lower as compared to mAOX1 and mAOX2.
In conclusion, this study focuses on the development of a simple and efficient system for the isolation and first comparative enzymatic characterization of the four mouse AOXs.
The system is likely to represent an important tool for the definition of the substrate specificity of each enzyme. At the basic level, the identification of the common and specific physiological substrates of each enzyme is likely to provide clues as to the functional role played by mAOX1, mAOX3, mAOX4 and mAOX2 in the homeostasis of the mouse. In fact, the existence of multiple and species-specific enzymatic forms of AOX is one of the most This article has not been copyedited and formatted. The final version may differ from this version. important and unresolved problems in the field. In particular, the presence of a single human AOX enzyme, i.e. AOX1, and multiple as well as tissue-specific AOXs in other animal species, with particular reference to mice and rats, has important ramifications not only in terms of basic biology but also at the applied level. In fact, human AOX1 is of emerging interest in the context of drug metabolism and development, as the enzyme is capable of oxidizing and potentially inactivating an ever increasing number of heteroaromatic rings which represent the principal components of numerous molecules of therapeutic and toxicological interest (Pryde et al., 2010) . Due to the existence of four different AOX enzymes in mice and rats and a single AOX enzyme in humans, the use of rodents as preclinical models for pharmacokinetic, pharmacodynamic and toxicological studies involving drugs which are potential human AOX1 substrates are generally not suitable model systems for these particular studies (Sanoh et al., 2015) . In this context, we propose that the availability of a system which allows the purification of large amounts of catalytically active human (Foti et al., 2016) and mouse AOXs is likely to be the basis for screening tests aimed at establishing whether new drug candidates and available drugs represent efficient substrates for this class of enzymes. We therefore propose to directly use the purified enzymes for studies on substrate conversion, since without cross-contaminations with other enzymes the mode of substrate conversion and inhibition can be investigated directly in molecular detail. 
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